3 Pot Stocks to Avoid Like the Plague in December

The market has had a tough year, but North American pot stocks have thrived. The coronavirus disease 2019 (COVID-19) pandemic hasn’t deterred consumers eager to buy cannabis products. In Canada, licensed cannabis store sales hit yet another all-time high in September ($197.5 million)…

But as investors, we also know that not every company in a high-growth industry can be a winner. As we prepare to turn the page on 2020, my suggestion would be to avoid the following three pot stocks like the plague in December.

Aurora Cannabis

Canadian licensed producer Aurora Cannabis (NYSE:ACB) should be a permanent fixture in this monthly column. Although it’s been on fire since the U.S. election last month, there are many reasons I’m not buying into the misplaced euphoria surrounding this company.

At the moment, investors seem excited about the prospects for legalization; Joe Biden won the White House, and the Democrat-led House of Representatives will vote on the MORE Act this month. The Marijuana Opportunity, Reinvestment, and Expungement Act would decriminalize cannabis at the federal level and impose a retail tax on legal weed sales.

This sounds great on paper, but Biden’s decriminalization plan has issues. Further, the MORE Act is dead on arrival as long as Sen. Mitch McConnell remains Senate Majority Leader. A House vote is nothing more than a talking point, which means Aurora is still far from entering the U.S. pot industry.

The bigger issue with Aurora Cannabis has always been its complete disregard for its shareholders. Whether to finance acquisitions or internal expansion, Aurora has often sold its common stock to raise capital. Between June 2014 and October 2020, its share count grew by more than 11,800% — and it’s not finished. Recently, the company’s board approved a $500 million shelf offering that’ll mean ongoing dilution.

Though most of Aurora’s previous management team is gone, investors continue to suffer for their mistakes. In fiscal 2020 (ended June 30, 2020), Aurora recorded a $3.3 billion Canadian net loss, much of which can be attributed to goodwill and asset writedowns. The company was far too overzealous in the capacity expansion department and was forced to close facilities, lay off workers, and take huge impairment charges in fiscal 2020.

As the icing on the cake, Aurora continues to move back the goalposts for achieving positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA). There’s no reason to trust management or invest in this marijuana stock.

Sundial Growers

Another blazing-hot pot stock that investors would be smart to avoid in December is small-cap Sundial Growers (NASDAQ:SNDL).

Shares of Sundial more than quadrupled in November for many of the same reasons described above. Additionally, on Nov. 11, the company reported its third-quarter operating results that featured a CA$23 million reduction in debt and lower general and administrative expenses. Given the company’s shift away from wholesale cannabis and toward higher-margin branded retail sales, investors have liked what they’ve seen.

Yet this company is still a hot mess.

One of the more front-and-center issues for Sundial is…

Continue reading at THE MOTLEY FOOL

 

 

 

You May Also Like

About the Author: admin

Leave a Reply

Your email address will not be published.